CA Stock MarketDetailed Quotes

GUD Knight Therapeutics Inc

Watchlist
  • 5.920
  • +0.020+0.34%
15min DelayMarket Closed Apr 28 16:00 ET
589.28MMarket Cap148.00P/E (TTM)

Knight Therapeutics Inc Key Stats

Knight Therapeutics Inc Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CAD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 97.531M--
--2025/Q1-- / 87.672M--
Mar 20, 20252024/Q496.864M / 87.621M--
Nov 7, 20242024/Q392.263M / 89.426M--
Aug 8, 20242024/Q295.573M / 87.667M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 97.531M--
--2025/Q1-- / 87.672M--
Mar 20, 20252024/Q496.864M / 87.621M--
Nov 7, 20242024/Q392.263M / 89.426M--
Aug 8, 20242024/Q295.573M / 87.667M--

Unlock Free Earnings Estimates

Knight Therapeutics Inc Earnings Reports

Read more

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

Unlock Now

Discussing

2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current Show More